Ovid Therapeutics Inc (OVID) Stock Analysis

Sector: HEALTHCARE - BIOTECHNOLOGY

Exchange: NASDAQ

Key Metrics

• Price: $1.65
• Market Cap: $115.36M
• EPS: $-0.50
• 52-Week High: $2.01
• 52-Week Low: $0.24

Market Sentiment

Ovid Therapeutics Inc currently has a Bullish sentiment score of 0.19.

About Ovid Therapeutics Inc

Ovid Therapeutics Inc. is a biopharmaceutical company based in New York, dedicated to creating innovative therapies for patients and families affected by neurological disorders. The firm focuses on developing impactful medications with a strong emphasis on addressing unmet medical needs in this complex and under-researched area. With a robust pipeline of product candidates, Ovid positions itself as a leader in advancing treatments that aim to improve the quality of life for patients suffering...

GNG Research provides proprietary Safety Scores, Quality Scores, Fair Value estimates, and Valuation Ratings for Ovid Therapeutics Inc and 4,500+ other companies. Learn more about GNG Pro.

Frequently Asked Questions

Does OVID pay dividends?

Ovid Therapeutics Inc (OVID) does not currently pay a regular dividend.

What is OVID's market cap?

Ovid Therapeutics Inc (OVID) has a market capitalization of $115.36M with a current stock price of $1.65.